# Semaglutide vs Liraglutide: Differences & Which to Consider **By TelosRX Editorial Team** · 2026-10-18 **Semaglutide vs liraglutide comes down to schedule and size of effect. Semaglutide is a once-weekly GLP-1 shot, liraglutide is a once-daily one, and in a head-to-head trial semaglutide produced more average weight loss. [TelosRX](https://telosrx.com) providers review which fits you.** Both drugs copy the same gut hormone. Both come from the same manufacturer. So why do people keep asking which one is better? Because the differences show up where you actually live: how often you inject, how fast you titrate, and what the trials measured. This guide puts semaglutide vs liraglutide side by side. You'll get a comparison table, what the only head-to-head weight trial found, and how a licensed provider decides between them. ## Semaglutide vs Liraglutide at a Glance Here's the short version before the details. Every figure below comes from FDA labeling or the cited trial. Feature Semaglutide Liraglutide Drug class GLP-1 receptor agonist GLP-1 receptor agonist Brand names Ozempic, Wegovy (injection); Rybelsus (tablet) Victoza, Saxenda (injection) Dosing frequency Once weekly (injection) Once daily Half-life About 1 week About 13 hours Top weight-management dose 2.4 mg weekly (Wegovy) 3.0 mg daily (Saxenda) Titration to top dose 16 weeks in STEP 8 4 weeks in STEP 8 Average weight change, STEP 8 (68 weeks) −15.8% −6.4% GI side effects reported, STEP 8 84.1% 82.7% Stopped treatment for any reason, STEP 8 13.5% 27.6% Generic available in the US No Yes, for some liraglutide products Trial averages describe groups, not you. Individual results vary, and a provider weighs your history before recommending either one. ## What Semaglutide and Liraglutide Have in Common Both are GLP-1 receptor agonists. That means they mimic glucagon-like peptide-1, a gut hormone released after you eat. GLP-1 signaling does three main jobs: - **Slows stomach emptying**, so meals feel fuller for longer. - **Quiets appetite signals** in the brain's hunger centers. - **Supports insulin release** when blood sugar is high. Both drugs were engineered from the same starting point. Each one has a fatty-acid chain attached that lets it bind to albumin, a blood protein. That trick keeps the molecule in circulation far longer than natural GLP-1, which lasts only minutes. ## The Big Difference: Half-Life and Dosing Schedule Semaglutide's half-life is roughly one week. Liraglutide's is about 13 hours. That one gap drives almost everything else. A week-long half-life allows a single weekly injection. A 13-hour half-life means liraglutide needs a shot every day to keep levels steady. For a lot of people, this is the deciding factor. Fifty-two injections a year is a different lifestyle from 365. Then again, some people like a daily routine. It's easier to remember than a weekly one, and missed days are simpler to sort out. ## What the Head-to-Head Trial Found The best comparison data comes from STEP 8, a 68-week randomized trial published in _JAMA_ in 2022. It enrolled 338 adults with overweight or obesity who did not have diabetes. You can read the full results in the [STEP 8 trial report](https://pmc.ncbi.nlm.nih.gov/articles/PMC8753508/). Participants took either weekly semaglutide 2.4 mg or daily liraglutide 3.0 mg. Both groups also followed diet and activity counseling. Here's what the researchers reported: - **Average weight change:** −15.8% with semaglutide vs −6.4% with liraglutide. - **Side effects:** GI complaints were similar, at 84.1% vs 82.7%. - **Staying on treatment:** 13.5% stopped semaglutide early, compared with 27.6% for liraglutide. Two caveats matter. The trial was open-label, so participants knew which drug they took. It was also funded by the manufacturer of both drugs. The trial registration is public on [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT04074161). ## Side Effects Compared The side-effect profiles look alike because the drugs work the same way. Most complaints are digestive and show up during dose increases. Side effect Semaglutide Liraglutide Nausea Common, mostly during titration Common, mostly during titration Diarrhea or constipation Common Common Vomiting Less common Less common Injection-site reactions Possible Possible, with more injections overall Gallbladder issues Labeled warning Labeled warning Thyroid C-cell tumor boxed warning Yes Yes Both labels carry the same boxed warning about thyroid C-cell tumors seen in rodents. Neither is used in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Your provider screens for this before approval. Slow titration is the main tool for easing GI effects. Our guide to [semaglutide drug interactions](https://telosrx.com/blogs/glp1/semaglutide-drug-interactions) also covers medications worth flagging on your intake. ## FDA-Approved Uses for Each The brand products have different FDA-approved indications. This matters because the label defines what the evidence supports. - **Wegovy (semaglutide):** chronic weight management, and reducing the risk of major cardiovascular events in adults with established heart disease and obesity or overweight. - **Ozempic (semaglutide):** blood sugar control in type 2 diabetes, plus cardiovascular and kidney risk reduction in certain adults with type 2 diabetes. - **Rybelsus (oral semaglutide):** blood sugar control in type 2 diabetes. - **Saxenda (liraglutide):** chronic weight management in adults and children 12 and older. - **Victoza (liraglutide):** blood sugar control in type 2 diabetes, plus cardiovascular risk reduction in adults with heart disease. Compounded versions of these molecules are a separate category. They are not FDA-approved, and the FDA has published [its concerns about unapproved GLP-1 drugs](https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss). Any compounded option is prescribed only after an individual provider review. ## Cost and Access Cost is where liraglutide sometimes has an edge. Generic liraglutide has reached the US market for some products, which can lower the price compared with brand names. Semaglutide has no US generic at the time of writing. Coverage for either drug depends on your insurance plan and the indication. Weight-management coverage is often more limited than diabetes coverage. If you want to see how TelosRX structures GLP-1 options, the [TelosRX semaglutide program page](https://telosrx.com/pages/semaglutide) explains the process. Every prescription is subject to medical approval by a licensed provider. ## Which to Consider: How Providers Decide There's no universal winner. A provider looks at your goals, history, and preferences. Common factors include: 1. **Injection preference.** Weekly suits people who dislike frequent shots. Daily suits people who prefer a fixed routine. 2. **Size of effect needed.** In STEP 8, semaglutide produced the larger average weight change. 3. **Tolerability history.** Someone who struggled with one GLP-1 may be evaluated for another. 4. **Medical history.** Thyroid history, pancreatitis, gallbladder disease, and kidney function all count. 5. **Budget and coverage.** Generic liraglutide may change the math for some people. Still weighing other molecules too? Our [GLP-1 options comparison](https://telosrx.com/pages/glp-1-options) lays out tirzepatide and semaglutide side by side. ## Protecting Muscle on Either Drug Whichever GLP-1 you use, part of the weight lost can be lean mass. That's true across the class, not just for one drug. Practical habits help: hit a protein target, lift weights two to three times a week, and track body composition rather than just scale weight. Our breakdown of the [signs of muscle loss on GLP-1](https://telosrx.com/blogs/glp1/signs-of-muscle-loss-on-glp1) shows what to watch. ## How the TelosRX Process Works TelosRX is an asynchronous telehealth service. You complete a secure online intake on your own time. There's no live video call to schedule. A licensed provider reviews your history and labs, then decides whether a GLP-1 is appropriate. If approved, your prescription ships to you. Messaging with the care team stays open for follow-up questions. ## Frequently Asked Questions ### Is semaglutide stronger than liraglutide? In the STEP 8 trial, weekly semaglutide 2.4 mg produced an average weight change of −15.8% at 68 weeks. Daily liraglutide 3.0 mg produced −6.4%. That makes semaglutide more effective on average in that study. Individual responses still vary, and a licensed provider weighs your history before recommending either drug. ### Can you switch from liraglutide to semaglutide? Yes, switching between GLP-1 drugs is common in clinical practice. A provider usually stops the daily drug and starts the weekly one at a low dose, then titrates up. The exact plan depends on your current dose and how well you tolerated it. Never switch on your own; any change is subject to provider approval. ### Do semaglutide and liraglutide have the same side effects? Mostly, yes. Both commonly cause nausea, diarrhea, constipation, and occasional vomiting, especially during dose increases. In STEP 8, GI side effects were reported by 84.1% on semaglutide and 82.7% on liraglutide. Both labels carry the same boxed warning about thyroid C-cell tumors seen in rodent studies. ### Why is liraglutide taken daily but semaglutide weekly? It comes down to half-life. Liraglutide has a half-life of about 13 hours, so levels drop within a day. Semaglutide's half-life is roughly one week because its structure binds blood proteins more tightly and resists breakdown. That longer half-life is what allows a single weekly injection. ### Is generic liraglutide the same as Victoza or Saxenda? An FDA-approved generic must contain the same active ingredient, strength, and dosage form as the brand, and show bioequivalence. So an approved generic liraglutide works the same way as its reference brand. Compounded liraglutide is different: it is not FDA-approved and is not the same as an approved generic. ### Which is better for type 2 diabetes, semaglutide or liraglutide? Both are FDA-approved brands for blood sugar control in type 2 diabetes, and both have cardiovascular outcome data. Trials comparing the diabetes doses have generally favored semaglutide for A1C and weight reduction. Your clinician considers kidney function, heart history, and injection preference when choosing between them. _TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ Start your private evaluation at [TelosRX](https://telosrx.com). **Tags:** comparison, GLP-1 comparison, liraglutide, semaglutide, Wegovy vs Saxenda, weight management --- > Source: [Telos RX](https://www.telosrx.com/blogs/glp1/semaglutide-vs-liraglutide-comparison)